Drug discovery

Business financing
#Artificial intelligence (AI) #Drug development #Drug discovery #Financing

Tres Alchemix closes $4.4 million financing round

AI-driven biotechnology company Tres Alchemix has closed its $4.4 million Series A financing round, the company has announced.  New funding will be used to accelerate the development of Tres Alchemix’s predictive AI platform and support the opening of a new laboratory at The Oxford Science Park, a hub of world-leading… Read More

#Business & Investment #News #Start-up Zone

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #Personalised medicine #Webinar

Webinar: Explore strategies to streamline biomarker discovery

Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. Taking place on 23 October at 4pm BST, this webinar, hosted by DDW and supported by Danaher Life… Read More

Webinar date:
Supported by Danaher
#News

#Biopharmaceuticals #Drug discovery #High throughput screening #Sartorius

Advancing global health through innovation

This paid-for advertorial from Sartorius appeared in DDW Volume 26 – Issue 4, Fall 2025 The global health landscape is complex and constantly shifting, presenting multifaceted challenges for the pharmaceutical industry. To keep pace, companies must deliver more targeted therapies in less time, often with fewer resources. Advances in areas… Read More

#Exclusive Content

London skyline
#DDW Turning Science into Business Symposium #Drug discovery #Events #The Francis Crick Institute

Chas Bountra, Oxford Uni, confirmed to speak at DDW Symposium

The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November. DDW is delighted to welcome Chas Bountra Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University to the expert speaker line-up. Bountra… Read More

#News

eBook: The impact of ADCs on drug discovery
#Antibody drug conjugate (ADC) #Drug discovery #eBook #Therapeutic Antibodies

The impact of ADCs on drug discovery

This eBook, sponsored by Abzena, explores the latest developments in the ADC field and the opportunities presented by next generation bioconjugates.

#DDW eBooks #Intelligence

#Artificial intelligence (AI) #Biologics #Drug discovery

Enabling AI in chemistry and biologics discovery

This paid-for advertorial from CDD Vault appeared in DDW Volume 26 – Issue 4, Fall 2025   CDD Vault outlines what to look for in an SDMP across chemistry and biologics using examples from CDD Vault and other leading platforms.  AI and machine learning are accelerating structure-activity relationship (SAR) predictions… Read More

#Exclusive Content

#Cancer research #Drug discovery

Ebook: The impact of ADCs on drug discovery

Antibody-drug conjugates (ADCs) offer a targeted approach to cancer treatment, combining the specificity of antibodies with the potency of cytotoxic drugs, and have shown promise in improving patient outcomes. This eBook, sponsored by Abzena, explores the latest developments in the ADC field and the opportunities presented by next generation bioconjugates. Read More

#DDW eBooks

#Assays #bit bio #Disease modelling #Drug discovery #iPSC #iPSC-derived cells

Listicle: Get the best out of human iPSC derived cells in your assays

Watch this DDW listicle, 5 ways to get the best out of human iPSC-derived cells in your assays from bit.bio, for free now. Transitioning to human iPSC-derived cells can open powerful opportunities for drug discovery, neuroscience, and disease modelling, but success depends on how you handle and culture them. Read More

#News

Synapses in the brain
#Drug discovery #eBook #Regenerative Medicine #Rejuvenation therapies

eBook: Unlocking the power of regenerative medicine

The term “regenerative medicine” is used to refer to methods to replace or regenerate human cells, tissues or organs to restore or establish normal function. This includes cell therapies, tissue engineering, gene therapy and biomedical engineering techniques, as well as more traditional treatments involving pharmaceuticals, biologics and devices. Read More

#News

#Cell Science #Drug discovery #Therapeutic Antibodies

Breaking barriers in cell and gene therapy ed led webinar Sept 2025

Hosted by Drug Discovery World and sponsored by Oxford Nanopore Technologies, this webinar explores developments in CGT drug discovery and development. You will hear from Brian Culley, CEO of Lineage Cell Therapeutics, Will Decker, CSO of Diakonos Oncology, and John Maher, Scientific Founder and CSO of Leucid Bio. In… Read More

#Webinars

Vaccine
#Drug development #Drug discovery #Immunology / Virology & Vaccines #mRNA-based vaccines

The expanding market of vaccines  

By Stephen Adams, Associate Director, Optimum Strategic Communications  To say that vaccines and vaccine makers have been on a popularity rollercoaster in recent years is an understatement. Five years ago, with the world’s biotechs and pharma firms engaged in a high-stakes race to develop the first Covid vaccines, the mood… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #Personalised medicine #Webinar

Webinar: Innovative AI software solutions driving biomarker research

Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. Taking place on 23 October at 4pm BST, this webinar, hosted by DDW and supported by Danaher Life… Read More

Webinar date:
Supported by Danaher
#News

#AI #Drug discovery #Financing

DaltonTx set to build AI-enabled drug discovery platforms

UK-based technology company DaltonTx has announced the completion of a £4 million ($5.4 million) financing round to build adaptive AI-enabled drug discovery platforms.  The company, which exited from stealth, is planning on building platforms giving research teams instant access to AI-enabled drug discovery, bypassing their need for… Read More

#News

#Cell Science #Drug discovery

Ebook: Unlocking the power of regenerative medicine

The term “regenerative medicine” is used to refer to methods to replace or regenerate human cells, tissues or organs to restore or establish normal function. This eBook, sponsored by ThinkCyte, examines the latest advances in the sector and the market potential for regenerative medicine. Download this exclusive eBook to… Read More

#DDW eBooks